T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 85 filers reported holding T2 BIOSYSTEMS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 19,668 | -5.5% | 0.00% | – |
Q2 2022 | $3,000 | -50.0% | 20,818 | +85.6% | 0.00% | – |
Q1 2022 | $6,000 | +20.0% | 11,214 | +11.4% | 0.00% | – |
Q4 2021 | $5,000 | -86.1% | 10,064 | -74.7% | 0.00% | – |
Q3 2021 | $36,000 | -21.7% | 39,764 | +2.1% | 0.00% | – |
Q2 2021 | $46,000 | +17.9% | 38,964 | +60.8% | 0.00% | – |
Q1 2021 | $39,000 | +56.0% | 24,234 | +21.6% | 0.00% | – |
Q4 2020 | $25,000 | +31.6% | 19,934 | +40.4% | 0.00% | – |
Q3 2020 | $19,000 | +5.6% | 14,200 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | -25.0% | 14,200 | -62.2% | 0.00% | – |
Q1 2020 | $24,000 | +50.0% | 37,600 | +168.6% | 0.00% | – |
Q4 2019 | $16,000 | -62.8% | 14,000 | -17.6% | 0.00% | – |
Q3 2019 | $43,000 | +38.7% | 17,000 | +11.8% | 0.00% | – |
Q1 2019 | $31,000 | -46.6% | 15,200 | -20.8% | 0.00% | – |
Q4 2018 | $58,000 | -48.2% | 19,200 | +28.0% | 0.00% | – |
Q3 2018 | $112,000 | +1144.4% | 15,000 | +782.4% | 0.00% | – |
Q4 2016 | $9,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |